FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

COXSACKIE A2 CF ANTIGEN, A4, A10 & A16

K Number: K853279 · Decision Nov 7, 1985
Classifications
1
FEI Numbers
0
Registration Numbers
0
Same Product Code
0
Applicant Total
33
Review Days
94

Basic Information

Device Name
COXSACKIE A2 CF ANTIGEN, A4, A10 & A16
K Number
K853279
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
866.3145
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Applicant
HILLCREST BIOLOGICALS
Date Received
August 5, 1985
Decision Date
November 7, 1985
Product Code
GNO
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GNO Antisera, Cf, Coxsackievirus A 1-24, B 1-6

Other Clearances by HILLCREST BIOLOGICALS

K Number Device Name
K913617 ARBOVIRUS IGG IFA TEST
K913618 ARBOVIRUS IGM IFA TEST
K922374 Q FEVER IGM IFA TEST
K913906 Q FEVER IGG IFA TEST
K900206 LYME DISEASE IGM ELISA
K896594 EBV VCA ANTIBODY (IGM)
K884829 EBV EARLY ANTIGEN (R+D)
K883767 LYME DISEASE IFA (IGM)
K884591 EBV-VCA ANTIBODY (IGG)
K883487 LYME DISEASE IFA (IGG)
Search all 33 clearances from HILLCREST BIOLOGICALS →